Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 101 pseudogene 2 (ZNF101P2) is a human pseudogene located on chromosome 1q31.2. Pseudogenes are DNA segments similar to functional genes but are generally non-coding due to mutations or truncations that prevent protein production. ZNF101P2 shares sequence homology with zinc finger protein genes, which in general function as DNA-binding transcription factors. However, there is no evidence that ZNF101P2 is transcribed or translated into a functional protein, nor has it been implicated in any known physiological or pathophysiological processes. It is not considered a therapeutic target, and there are no drugs or clinical interventions associated with this pseudogene. Key points: - ZNF101P2 is a pseudogene, not an active gene or receptor. - Not a therapeutic target: It does not encode a protein or have known biological activity, so is not targeted in any disease or pathway. - No known disease or drug interactions: Has not been linked to pathology, drug action, or use as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 101 pseudogene 2 (ZNF101P2).